Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › BioMérieux Blood Culture System Cleared by FDA

BioMérieux Blood Culture System Cleared by FDA

Apr 06, 2017

NEW YORK (360Dx) – BioMérieux announced today that its BacT/Alert Virtuo automated blood culture system has received 510(k) clearance from the US Food and Drug Administration. The system was previously CE marked and is now commercially available in the US and countries that recognize CE marking.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  2. BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

  3. FDA Grants Emergency Use Authorization for Jiangsu Well Biotech Coronavirus Antibody Test

  4. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  5. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.